Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation

In the Land of the Living Logistics

| James Strachan

Ideal drug manufacturing and logistic processes are closed and automated to eliminate the risks associated with human intervention and manual operations, but most cell and gene therapies are not yet at this stage. Here, we discuss the problems of handling living, breathing cells in transit.

Discovery & Development

Revolutionizing Medicine – While Learning “Novartian”

| James Strachan

Sitting Down With... Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania, USA.

Manufacture

Search and Destroy

| Joannis Manolopoulos

According to the International Anti-Counterfeiting Coalition, the illicit market of counterfeit drugs has a global value of more than one trillion Euros. Serialization will certainly help in the battle against counterfeiters, but there are other steps that manufacturers can take.

Latest Articles

Business & Regulation

What it Takes to Bloom

| James Strachan

Cell and gene therapies can live up to their potential – the field just needs to transform medicine as we know it.

Discovery & Development

Advancing Therapies

| James Strachan

A report highlights the acceleration of cell and gene therapy approvals worldwide.

Business & Regulation

News-in-Brief

| James Strachan

Converting glial cells to neurons, more effective CAR-Ts, and groundbreaking IDAs… What’s new in the advanced medicine field?

Business & Regulation

A True Dawn

| John Rasko

With all the hope and promise emanating from the cell and gene therapy field today, it’s easy to forget that we’ve had false dawns in the past.

Discovery & Development

Now for the High-Hanging Fruit

| Miguel Forte

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Manufacture

Command and Control Your Bioprocess

| Philipp Nold

The stem cell industry needs to embrace bioprocess control systems to develop consistent, high quality, and commercially viable bioprocesses.

Discovery & Development

Holding Back the Years

| Maryam Mahdi

How are scientists seeking inspiration from plants in the fight against Alzheimer’s disease?

Manufacture

Medicines Anywhere, Anytime

| Govind Rao

Why use a huge manufacturing facility when biological medicines can be made in a suitcase?

Business & Regulation

Staying the Course

| James Strachan

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.

Manufacture

Staying Flexible

| Firman Ghouze, Uriel Kusiatin

Rather than fearing the unknown, the concept of optionality can help you better manage it.

All Articles

Upcoming Events

-

Eye for Pharma

Barcelona, Spain

-

DCAT

New York, USA

CAT Week ‘19: Business Development | Networking | Industry Education
DCAT Week is the premier business development...

All Events

Sister Publications

You might be interested in our Sister Publications:


Latest White Papers

Technology for combating counterfeit medicine

| Contributed by Malvern Panalytical

Toothpaste identification by FingerPrint

| Contributed by Malvern Panalytical

All White Papers

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker